The efficacy of additional metformin to aspirin for human rectal aberrant crypt foci: double-blinded randomized controlled trial

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2019
INTERVENTION: aspirin metformin medication CONDITION: Colorectal adenoma, carcinoma in situ ; Colorectal Neoplasm Colorectal Neoplasm PRIMARY OUTCOME: The amount of change rectal ACF in aspirin plus placebo group and aspirin plus metformin group after 8weeks intervention SECONDARY OUTCOME: The number of rectal ACF before and after intervention in both group ; Ki67 labeling index of colorectal adenoma/cancer and normal mucosa before and after intervention ; Safety INCLUSION CRITERIA: Patients both with rectal ACF and resectable polyps
Epistemonikos ID: 2c90037b3fb7d9158347f89f9ffa92538e6cf0b6
First added on: Aug 24, 2024